Amgen Mvasi, Kanjinti Sales Decline As Biosimilars Industry Faces New Policy Challenges

 
• By Cathy Kelly
  
How A Unique Feature Of US Reimbursement Impacts Biosimilars • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics